FDA Approved: SORAFENIB TOSYLATE — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a generic sorafenib tosylate product from Mylan under an original application. Sorafenib is indicated for hepatocellular carcinoma, renal cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Carcinoma
• Hepatocellular Carcinoma
• Renal Cell Carcinoma

Drugs mentioned

• Sorafenib tosylate (sorafenib tosylate)

Snippet

ORIG AP for SORAFENIB TOSYLATE (SORAFENIB)